Qube Research & Technologies (QRT)
AGIO icon

Qube Research & Technologies (QRT)’s Agios Pharmaceuticals AGIO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.2M Buy
597,638
+409,971
+218% +$12.4M 0.02% 861
2026
Q1 		$6.35M Sell
187,667
-190,706
-50% -$5.41M 0.01% 1539
2025
Q4 		$10.3M Buy
+378,373
New +$13.3M 0.01% 1324
2025
Q3 		– Sell
-67,379
Closed -$2.24M – 3534
2025
Q2 		$2.24M Sell
67,379
-60,601
-47% -$1.84M ﹤0.01% 2158
2025
Q1 		$3.75M Sell
127,980
-71,990
-36% -$2.39M ﹤0.01% 1681
2024
Q4 		$6.57M Buy
199,970
+115,553
+137% +$5.43M 0.01% 1343
2024
Q3 		$3.75M Buy
84,417
+59,587
+240% +$2.71M 0.01% 1524
2024
Q2 		$1.07M Sell
24,830
-18,414
-43% -$665K ﹤0.01% 1853
2024
Q1 		$1.26M Sell
43,244
-74,268
-63% -$1.99M ﹤0.01% 2011
2023
Q4 		$2.62M Buy
+117,512
New +$2.63M 0.01% 1394
2023
Q1 		– Sell
-39,061
Closed -$1.1M – 2492
2022
Q4 		$1.1M Buy
+39,061
New +$1.1M 0.01% 1186
2022
Q3 		– Sell
-84,801
Closed -$1.88M – 2467
2022
Q2 		$1.88M Buy
84,801
+49,335
+139% +$1.11M 0.01% 844
2022
Q1 		$1.03M Buy
35,466
+1,225
+4% +$37.4K 0.01% 1150
2021
Q4 		$1.13M Buy
+34,241
New +$1.38M 0.01% 1120
2020
Q4 		– Sell
-17,385
Closed -$608K – 1767
2020
Q3 		$608K Buy
+17,385
New +$762K 0.01% 973
2020
Q2 		– Sell
-13,009
Closed -$462K – 1687
2020
Q1 		$462K Buy
+13,009
New +$601K 0.02% 587

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Qube Research & Technologies (QRT)'s AGIO Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Agios Pharmaceuticals (AGIO) stake by 218% in Q2 2026, buying an estimated $12.4M and bringing the position to 597,638 shares worth $22.2M. The position accounts for 0.02% of the portfolio, ranked #861.

Qube Research & Technologies (QRT) first reported a position in AGIO in Q1 2020 and has held it in 16 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Qube Research & Technologies (QRT) held 597,638 shares of Agios Pharmaceuticals worth $22.2M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 409,971 Agios Pharmaceuticals shares in Q2 2026, an estimated $12.4M.
  • Agios Pharmaceuticals made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #861 holding.
  • Qube Research & Technologies (QRT) first reported a position in Agios Pharmaceuticals in Q1 2020 and has held it in 16 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.